David Peritt

David Peritt is the Founder and CSO of Lupagen, a company focused on creating a closed loop autologous cell modification system for bedside cell therapy. In addition, David serves as an Adjunct Professor at Northwestern University's McCormick School of Engineering and is a member of various science and technology committees. Peritt has held key roles at companies like Sigilon Therapeutics, Pfizer, and Hospira, with a background in immunology and a Ph.D. from the University of Pennsylvania.